SG Americas Securities’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-69,385
| Closed | -$1.05M | – | 3492 |
|
|
2022
Q3 | $1.05M | Buy |
69,385
+52,635
| +314% | +$612K | 0.01% | 990 |
|
|
2022
Q2 | $126K | Buy |
+16,750
| New | +$118K | ﹤0.01% | 2975 |
|
|
2022
Q1 | – | Sell |
-112,421
| Closed | -$789K | – | 3620 |
|
|
2021
Q4 | $789K | Sell |
112,421
-26,893
| -19% | -$281K | ﹤0.01% | 1810 |
|
|
2021
Q3 | $1.59M | Buy |
139,314
+43,527
| +45% | +$636K | 0.01% | 1493 |
|
|
2021
Q2 | $1.53M | Buy |
95,787
+54,892
| +134% | +$942K | 0.01% | 1287 |
|
|
2021
Q1 | $731K | Sell |
40,895
-42,954
| -51% | -$742K | ﹤0.01% | 1747 |
|
|
2020
Q4 | $1.13M | Buy |
83,849
+65,144
| +348% | +$787K | 0.01% | 1470 |
|
|
2020
Q3 | $220K | Sell |
18,705
-1,405
| -7% | -$17.1K | ﹤0.01% | 2094 |
|
|
2020
Q2 | $297K | Sell |
20,110
-273,480
| -93% | -$4.05M | ﹤0.01% | 2524 |
|
|
2020
Q1 | $3.96M | Buy |
293,590
+288,028
| +5,178% | +$5.46M | 0.04% | 466 |
|
|
2019
Q4 | $134K | Buy |
+5,562
| New | +$115K | ﹤0.01% | 2774 |
|
|
2019
Q2 | – | Sell |
-8,440
| Closed | -$401K | – | 3543 |
|
|
2019
Q1 | $401K | Sell |
8,440
-2,938
| -26% | -$129K | ﹤0.01% | 2027 |
|
|
2018
Q4 | $411K | Buy |
+11,378
| New | +$534K | ﹤0.01% | 1992 |
|
|
2018
Q3 | – | Sell |
-1,708
| Closed | -$115K | – | 3547 |
|
|
2018
Q2 | $115K | Sell |
1,708
-1,096
| -39% | -$61.3K | ﹤0.01% | 2988 |
|
|
2018
Q1 | $152K | Sell |
2,804
-9,527
| -77% | -$533K | ﹤0.01% | 2633 |
|
|
2017
Q4 | $737K | Sell |
12,331
-1,844
| -13% | -$112K | 0.01% | 1592 |
|
|
2017
Q3 | $689K | Buy |
14,175
+2,723
| +24% | +$149K | 0.01% | 1553 |
|
|
2017
Q2 | $602K | Sell |
11,452
-845
| -7% | -$39.3K | 0.01% | 1745 |
|
|
2017
Q1 | $558K | Sell |
12,297
-596
| -5% | -$26.6K | ﹤0.01% | 1774 |
|
|
2016
Q4 | $488K | Buy |
12,893
+9,297
| +259% | +$352K | ﹤0.01% | 1718 |
|
|
2016
Q3 | $136K | Buy |
+3,596
| New | +$79.3K | ﹤0.01% | 2810 |
|
|
2015
Q1 | – | Sell |
-4,585
| Closed | -$134K | – | 3175 |
|
|
2014
Q4 | $134K | Buy |
+4,585
| New | +$116K | ﹤0.01% | 2731 |
|
SG Americas Securities's AERI Position: Q4 2022 in Review
SG Americas Securities sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 69,385 shares — an estimated $1.05M sold.
SG Americas Securities first reported a position in AERI in Q4 2014 and held it in 22 quarters. The position peaked at $3.96M in Q1 2020. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- SG Americas Securities reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- SG Americas Securities sold 69,385 Aerie Pharmaceuticals shares in Q4 2022, an estimated $1.05M.
- SG Americas Securities first reported a position in Aerie Pharmaceuticals in Q4 2014 and held it in 22 quarters.
- SG Americas Securities's Aerie Pharmaceuticals position peaked at $3.96M in Q1 2020.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on SG Americas Securities's 13F filing for Q4 2022, filed 2 Feb 2023.